Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells

PLoS One. 2015 Apr 14;10(4):e0122398. doi: 10.1371/journal.pone.0122398. eCollection 2015.

Abstract

Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailability is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high expression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis and vasodilation; thus, a protective role of insulin on high D-glucose-alterations in endothelial function is likely. Vascular reactivity to U46619 (thromboxane A2 mimetic) and calcitonin gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose. hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein kinases (p42/44mapk), protein kinase B/Akt (Akt) expression and activity were determined by western blotting and qRT-PCR, tetrahydrobiopterin (BH4) level was determined by HPLC, and L-arginine transport (0-1000 μmol/L) was measured in response to 5-25 mmol/L D-glucose (0-36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs). Assays were in the absence or presence of insulin and/or apocynin (nicotinamide adenine dinucleotide phosphate-oxidase [NADPH oxidase] inhibitor), tempol or Mn(III)TMPyP (SOD mimetics). High D-glucose increased hCAT-1 expression and activity, which was biphasic (peaks: 6 and 24 hours of incubation). High D-glucose-increased maximal transport velocity was blocked by insulin and correlated with lower hCAT-1 expression and SLC7A1 gene promoter activity. High D-glucose-increased transport parallels higher reactive oxygen species (ROS) and superoxide anion (O2•-) generation, and increased U46619-contraction and reduced CGRP-dilation of vein rings. Insulin and apocynin attenuate ROS and O2•- generation, and restored vascular reactivity to U46619 and CGRP. Insulin, but not apocynin or tempol reversed high D-glucose-increased NO synthesis; however, tempol and Mn(III)TMPyP reversed the high D-glucose-reduced BH4 level. Insulin and tempol blocked the high D-glucose-increased p42/44mapk phosphorylation. Vascular dysfunction caused by high D-glucose is likely attenuated by insulin through the L-arginine/NO and O2•-/NADPH oxidase pathways. These findings are of interest for better understanding vascular dysfunction in states of foetal insulin resistance and hyperglycaemia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Acetophenones / pharmacology
  • Arginine / metabolism
  • Biopterins / analogs & derivatives
  • Biopterins / metabolism
  • Calcitonin Gene-Related Peptide / pharmacology
  • Cationic Amino Acid Transporter 1 / genetics
  • Cationic Amino Acid Transporter 1 / metabolism
  • Cyclic N-Oxides / pharmacology
  • Gene Expression Regulation
  • Glucose / antagonists & inhibitors
  • Glucose / pharmacology*
  • Human Umbilical Vein Endothelial Cells / cytology
  • Human Umbilical Vein Endothelial Cells / drug effects*
  • Human Umbilical Vein Endothelial Cells / metabolism
  • Humans
  • Insulin / pharmacology*
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Nitric Oxide / agonists
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase Type III / genetics
  • Nitric Oxide Synthase Type III / metabolism
  • Primary Cell Culture
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Reactive Oxygen Species / agonists
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism*
  • Signal Transduction
  • Spin Labels
  • Tissue Culture Techniques
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Umbilical Veins / drug effects*
  • Umbilical Veins / metabolism
  • Vasoconstrictor Agents / pharmacology

Substances

  • Acetophenones
  • Cationic Amino Acid Transporter 1
  • Cyclic N-Oxides
  • Insulin
  • Reactive Oxygen Species
  • SLC7A1 protein, human
  • Spin Labels
  • Transcription Factors
  • Vasoconstrictor Agents
  • WDR77 protein, human
  • Biopterins
  • Nitric Oxide
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Arginine
  • acetovanillone
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinase 1
  • sapropterin
  • Glucose
  • Calcitonin Gene-Related Peptide
  • tempol

Grants and funding

The work was supported by the following: Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT) (grant numbers 1110977, 11100192, 11110059, 3130583, 3140516), Chile; International NETWORK program (CONICYT) (grant number 130102), Chile; and Dirección de Investigación, Universidad de Concepción (DIUC) (grant number 210.033.103-1.0), Chile. RS is recipient of a Faculty of Medicine, Pontificia Universidad Católica de Chile-PhD fellowship; TS and RS hold CONICYT-PhD (Chile) fellowships; PA and LC held Universidad de Concepción-MSc (Chile) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.